Showing 20 of 86 recruiting trials for “squamous-cell-carcinoma-of-the-nasal-cavity-and-paranasal-sinuses”
Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma
GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma
👨⚕️ Jingao Li, MD, NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma, Jiangxi Cancer Hospital📍 1 site📅 Started Feb 2024View details ↗
A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
RecruitingNCT06307314 ↗
Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis
👨⚕️ Jian Guan, Ph.D., Nanfang Hospital, Southern Medical University📍 5 sites📅 Started Feb 2024View details ↗
A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors
RecruitingNCT06321939 ↗
Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma
Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma
👨⚕️ Jian Guan, MD, Nanfang Hospital, Southern Medical University📍 1 site📅 Started Oct 2023View details ↗
NBI Combined With MRI to Guide CTV Optimization in Eccentric Nasopharyngeal Carcinoma
👨⚕️ Ying Wang, Ph.D, M.D., Chongqing University Cancer Hospital📍 1 site📅 Started Oct 2023View details ↗
Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy
Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma
👨⚕️ Xiaozhong Chen, Department of Radiation Oncology, Zhejiang Cancer Hospital📍 1 site📅 Started Sep 2023View details ↗
The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
👨⚕️ Katherine R Sterba, PhD, MPH, Medical University of South Carolina📍 1 site📅 Started Aug 2023View details ↗
Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma
Metastatic Nasopharyngeal Carcinoma
Gemcitabine and Camrelizumab Plus Apatinib Versus Cisplatin in First-line Treatment of RM-NPC
Two Cycles VS Three Cycles Induction Chemotherapy in T1-4N2-3 Locally Advanced Nasopharyngeal Carcinoma
RecruitingNCT06662929 ↗
Arabic PRO Measures for Head and Neck Cancer Radiotherapy.
Intraoperative Ansa Cervicalis Nerve (ACN) Stimulation
👨⚕️ David T. Kent, MD, Vanderbilt University Medical Center📍 1 site📅 Started Feb 2023View details ↗
RecruitingNCT05884983 ↗
Screening Effect of Dual-energy CT Combined With Nasopharyngeal Endoscopy for Screening Nasopharyngeal Carcinoma
Nivolumab in Children and Adults With Nasopharyngeal Carcinoma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →